Orland Díez

Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients.

Petra Seibold, Hubert Thierens, Alison M Dunning, 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Molecular features of the basal-like breast cancer subtype based on BRCA1 mutation status

Charles M. Perou, Katherine A. Hoadley, Judith Balmaña, 2014, Breast Cancer Research and Treatment.

DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Olufunmilayo I. Olopade, Mads Thomassen, Torben A. Kruse, 2014, PLoS genetics.

A predictor based on the somatic genomic changes of the BRCA1/BRCA2 breast cancer tumors identifies the non-BRCA1/BRCA2 tumors with BRCA1 promoter hypermethylation.

Ana Osorio, Javier Benitez, Ramon Diaz-Uriarte, 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

PI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibition.

Lei He, Violeta Serra, Maurizio Scaltriti, 2012, Cancer discovery.

The variant E233G of the RAD51D gene could be a low‐penetrance allele in high‐risk breast cancer families without BRCA1/2 mutations

Pilar Zamora, Trinidad Caldés, Ana Osorio, 2004, International journal of cancer.

Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness.

Stefania Tommasi, Laura Cortesi, Mads Thomassen, 2019, Cancer research.